Notice: This company has been marked as potentially delisted and may not be actively trading. Otonomy (OTIC) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Otonomy, Inc. (OTIC) Stock Historical Prices & Data - Yahoo FinanceJanuary 23, 2023 | finance.yahoo.comOtonomy, Inc.: Otonomy Provides Corporate UpdateDecember 21, 2022 | finanznachrichten.deOtonomy Provides Corporate UpdateDecember 19, 2022 | finance.yahoo.comTrading was temporarily halted for "OTIC" at 04:12 PM with a stated reason of "News pending."December 19, 2022 | marketbeat.com5 Investors Betting Big on Otonomy (OTIC) StockNovember 30, 2022 | investorplace.comWhy Is Otonomy (OTIC) Stock Up 97% Today?November 29, 2022 | investorplace.comOtonomy Reports Third Quarter 2022 Financial Results and Provides Corporate UpdateNovember 10, 2022 | finance.yahoo.comOTIC.OQ - Otonomy Inc | Stock Price & Latest News | ReutersNovember 6, 2022 | reuters.comOTONOMY, INC. : Results of Operations and Financial Condition (form 8-K) - Marketscreener.comOctober 14, 2022 | marketscreener.comU.S. stocks higher at close of trade; Dow Jones Industrial Average up 2.83% By Investing.com - Investing.comOctober 13, 2022 | investing.comLianBio To Shut BridgeBio-Partnered Bile Duct Cancer Drug Trial - Yahoo FinanceOctober 13, 2022 | finance.yahoo.comU.S. stocks higher at close of trade; Dow Jones Industrial Average up 2.83% - StreetInsider.comOctober 13, 2022 | streetinsider.comOtonomy shares are trading lower after the company reported higher dose cohorts for OTO-413 demonstrated no clinically meaningful improvement for patients from baseline. - Otonomy (NASDAQ:OTIC) - BenzingaOctober 13, 2022 | benzinga.comOtonomy Sees No Clinically Meaningful Improvement With Higher Doses of OTO-413 in Patients With Hearing Loss -- Shares Nosedive - Marketscreener.comOctober 13, 2022 | marketscreener.comWhy Laser Photonics Shares Are Trading Higher By Around 44%, Here Are 50 Stocks Moving In Thursday’s Mid- - BenzingaOctober 13, 2022 | benzinga.comOtonomy Sees No Clinically Meaningful Improvement With Higher Doses of OTO-413 in Patients With Hearing Loss - Marketscreener.comOctober 13, 2022 | marketscreener.comOtonomy Reports Results from Clinical Evaluation of OTO-413 Higher Doses in Patients with Hearing Loss - GlobeNewswireOctober 13, 2022 | globenewswire.comOtonomy Reports Results from Clinical Evaluation of OTO-413 Higher Doses in Patients with Hearing Loss - Yahoo FinanceOctober 13, 2022 | finance.yahoo.comOtonomy Reports Results from Clinical Evaluation of OTO-413 Higher Doses in Patients with Hearing LossOctober 13, 2022 | finance.yahoo.comOTIC.O - Otonomy Inc | Stock Price & Latest News | ReutersOctober 7, 2022 | reuters.comAPPLIED GENETIC TECHNOLOGIES CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K) - Marketscreener.comSeptember 27, 2022 | marketscreener.comOTONOMY, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K) - Marketscreener.comSeptember 17, 2022 | marketscreener.comForm SC 13G/A OTONOMY, INC. Filed by: FEDERATED HERMES, INC. - StreetInsider.comSeptember 9, 2022 | streetinsider.comAGTC to Participate in Upcoming Investor Conferences - Yahoo FinanceSeptember 1, 2022 | finance.yahoo.comOtonomy : Costs Associated with Exit or Disposal Activities - Form 8-K - Marketscreener.comAugust 11, 2022 | marketscreener.comOTONOMY, INC. : Costs Associated with Exit or Disposal Activities, Change in Directors or Principal Officers (form 8-K) - Marketscreener.comAugust 9, 2022 | marketscreener.comShort Volatility Alert: Otonomy, Inc. - BenzingaAugust 6, 2022 | benzinga.comThis Healthcare Stock Is Trading Higher By 148%: Here Are 40 Stocks Moving PremarketAugust 3, 2022 | benzinga.comOTIC stock downgraded at H.C. Wainwright as tinnitus candidate fails (NASDAQ:OTIC) - Seeking AlphaAugust 2, 2022 | seekingalpha.comHC Wainwright Downgrades Otonomy to Neutral From Buy - Marketscreener.comAugust 2, 2022 | marketscreener.comDaily Biotech Pulse: Celyad Resumes Colorectal Cancer Trial, Setback For Otonomy, AstraZeneca Halts Phase 3 Head, Neck Cancer Trial By Benzinga - Investing.com UKAugust 2, 2022 | uk.investing.comOtonomy Shares Plumb New Depths on Failure of Lead Program >OTIC - MarketWatchAugust 2, 2022 | marketwatch.comAGTC to Participate in Upcomin - GuruFocus.comAugust 1, 2022 | gurufocus.comPiper Sandler Adjusts Otonomy Price Target to $3 From $6, Maintains Overweight Rating - Marketscreener.comAugust 1, 2022 | marketscreener.comVirax, Aethlon top healthcare gainers; while Otonomy, Kazia lead losers' pack - Seeking AlphaAugust 1, 2022 | seekingalpha.comOtonomy Shares Sink After Stopping Mid-Stage Tinnitus StudyAugust 1, 2022 | finance.yahoo.comOtonomy Reports Results From Phase 2 Clinical Trial Of OTO-313 In Patients With Tinnitus; Co. Reports 'OT - BenzingaAugust 1, 2022 | benzinga.comOtonomy Reports Results from Phase 2 Clinical Trial of OTO-313 in Patients with Tinnitus - GlobeNewswireAugust 1, 2022 | globenewswire.comOtonomy Reports Results from Phase 2 Clinical Trial of OTO-313 in Patients with TinnitusAugust 1, 2022 | finance.yahoo.comTrading was temporarily halted for "OTIC" at 07:08 AM with a stated reason of "News pending."August 1, 2022 | marketbeat.comOtonomy (NASDAQ:OTIC) Research Coverage Started at StockNews.comJuly 30, 2022 | americanbankingnews.comWalmart Cuts Q2, FY Profit Outlook; Stock Down - NasdaqJuly 27, 2022 | nasdaq.comTwo Clinical Studies to Treat Mild-to-Moderate COVID-19 at Home Reveal Value of Exscalate, Dompé's AI Platform for Drug Design - Yahoo FinanceJuly 27, 2022 | finance.yahoo.comOtonomy shares are trading lower after the company reported Q2 earnings results. - Benzinga - BenzingaJuly 26, 2022 | benzinga.comAGTC Receives Positive Type C Meeting Feedback from the FDA for the Company's Design and Operating Procedures of its Planned cGMP Manufacturing Facility - Marketscreener.comJuly 26, 2022 | marketscreener.comHealthStream EPS Tops Estimate, MEDP Revises Forecast, OTIC To Report Tinnitus Trial Data In August - RTTNewsJuly 26, 2022 | rttnews.comOtonomy (NASDAQ:OTIC) Announces Quarterly Earnings ResultsOtonomy (NASDAQ:OTIC - Get Rating) announced its quarterly earnings results on Monday. The biopharmaceutical company reported ($0.19) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.20) by $0.01. During the same quarter in the previous year, the company posted ($0.19) EPS.July 26, 2022 | marketbeat.comOtonomy Reports Second Quarter 2022 Financial Results and Provides Corporate Update - GlobeNewswireJuly 26, 2022 | globenewswire.comOtonomy Reports Second Quarter 2022 Financial Results and Provides Corporate UpdateJuly 25, 2022 | finance.yahoo.comOtonomy's Earnings Outlook - Benzinga - BenzingaJuly 22, 2022 | benzinga.com Get Otonomy News Delivered to You Automatically Sign up to receive the latest news and ratings for OTIC and its competitors with MarketBeat's FREE daily newsletter. Email Address TSLA *BANG* incoming (bullet in the chamber rn) (Ad)I just pinpointed 5 dirt-cheap stocks that could soar the second the shot goes off. Thanks to Donald Trump’s promise, and a secret Elon project set to revolutionize a $23 Trillion market… Click here to review Tim’s special Holiday offer before it’s too late. OTIC Media Mentions By Week OTIC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OTIC News Sentiment▼-0.240.59▲Average Medical News Sentiment OTIC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OTIC Articles This Week▼00▲OTIC Articles Average Week Get Otonomy News Delivered to You Automatically Sign up to receive the latest news and ratings for OTIC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies VRPX News Today SLRX News Today ATNF News Today PHIO News Today GLMD News Today PBM News Today PBLA News Today REVB News Today ONCT News Today GRTX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:OTIC) was last updated on 12/31/2024 by MarketBeat.com Staff From Our Partners$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Otonomy, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Otonomy With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
